How can dermatologists effectively position lebrikizumab as a treatment option to patients with atopic dermatitis, considering the variety of other available therapies?

Featuring Mona Shahriari, MD | Associate Clinical Professor of Dermatology, Yale University; Associate Director of Clinical Trials, Central CT Dermatology Research, Cromwell, CT | Published November 06, 2024